Addressing Common Questions About BioTexCom
Because surrogacy in Ukraine has received significant international media attention, some prospective parents may encounter critical or outdated information online. It is important to understand the context of these discussions.
Concern 1: “Surrogacy agencies in Ukraine exploit women”
One of the most common criticisms of international surrogacy programs is the concern that surrogate mothers may be exploited financially.
In reality, Ukrainian surrogacy programs operate under strict medical and legal regulations.
Surrogate mothers must:
- be adults who already have their own children
- undergo extensive medical screening
- pass a psychological evaluation
- voluntarily sign a legal agreement after having independent legal advice.
They receive full medical care during pregnancy, legal protection, and financial compensation that significantly exceeds the national average income.
Importantly, Ukrainian law recognises that surrogacy must be conducted only through licensed medical institutions, ensuring medical supervision and legal transparency.
Concern 2: “BioTexCom was involved in controversies”
Most of these reports were connected to extraordinary global events outside the control of fertility clinics, particularly the international travel restrictions during the COVID-19 pandemic in 2020.
During that time, strict border closures prevented many intended parents from entering Ukraine. As a result, several media outlets showed newborn babies temporarily waiting for their parents until international travel became possible again.
At one point, more than 100 newborn babies were under the care and protection of our medical and coordination teams while their parents were unable to travel due to global lockdowns.
For BioTexCom, this situation became an unprecedented stress test for the entire organization.
Our medical staff, coordinators, and neonatal specialists provided:
- 24-hour medical supervision
- neonatal care and monitoring
- safe accommodation for newborns
- constant communication with intended parents.
Once international travel restrictions were gradually lifted, all children were successfully reunited with their families.
This experience ultimately strengthened the clinic’s operational capacity and crisis management systems. The lessons learned during that period helped BioTexCom further improve its procedures for international coordination, logistics, and emergency planning for future surrogacy programs.
Today, the clinic continues to support international parents with a much stronger infrastructure developed during that challenging period. The pandemic unexpectedly demonstrated that a well-organised surrogacy program must be prepared not only for medical procedures, but also for global disruptions.
Concern 3: “Surrogacy in Ukraine is unsafe because of the war”
Since the full-scale invasion in 2022, some observers have questioned whether surrogacy programs can operate safely in Ukraine.
Despite the war, reproductive clinics have continued working and have implemented additional safety protocols.
More than 1,000 children have been born through surrogacy programs in Ukraine since the beginning of the war.
Clinics introduced measures such as:
- relocation planning when necessary
- cooperation with secure maternity hospitals
- contingency birth planning
- coordination with international embassies.
These steps allowed families from many countries to safely welcome their children even under challenging circumstances.
Concern 4: “Commercial surrogacy in Ukraine lacks regulation”
Another misconception is that surrogacy in Ukraine is unregulated.
In fact, Ukrainian legislation clearly regulates assisted reproductive technologies.
Key legal provisions include:
- Article 123 of the Family Code of Ukraine
- regulations of the Ministry of Health governing assisted reproduction.
These laws establish that:
- the intended parents are the legal parents from birth
- the surrogate mother has no parental rights
- the birth certificate lists the intended parents directly.
This legal clarity is one of the main reasons international couples choose Ukraine.
Concern 5: “Ukraine has too many surrogacy programs”
Ukraine’s surrogacy sector developed earlier than in many other countries and therefore became one of the largest international destinations.
This is largely due to several structural factors:
- a clear legal framework
- highly developed IVF medicine
- experienced fertility specialists
- a large population providing a broad pool of surrogate candidates.
The country’s population of over 35 million people allows clinics to maintain strict screening standards while still offering a reliable number of surrogate candidates.
International Recognition
Ukraine’s surrogacy industry has been widely covered by international media, including major outlets such as:
- BBC
- CNN
- The New York Times
- Deutsche Welle.
Many reports focused on the resilience of Ukrainian fertility clinics and the families who continued their surrogacy journeys even during global crises such as the pandemic and the war.
Large medical centers that conduct a high number of programs naturally generate more public attention and more individual stories. When thousands of surrogacy programs are conducted over many years, even rare or unusual situations can attract media interest.
Smaller clinics that conduct only a limited number of cases each year may appear in the media less frequently simply because their activities remain largely outside public attention.
As a result, the visibility of a clinic in international news coverage does not necessarily reflect the quality of its work. In many cases, it reflects the scale of operations and the number of international patients served.
For intended parents evaluating surrogacy providers, it is therefore important to look not only at isolated stories but also at the overall experience, number of completed programs, and long-term track record of successful births.
Clinics with large international programs often develop stronger operational systems precisely because they manage a higher volume of cases and must maintain consistent medical, legal, and logistical standards.
